Ricardo Costa

Dr. Ricardo Costa

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2021 in Surgery for Obesity and Related Diseases
Verified
Journal Article
Open access
LFLaura E. Fischer
Laura E. Fischer
BWBruce M. Wolfe
Bruce M. Wolfe
NFNora Fino
Nora Fino
MEMiriam R. Elman
Miriam R. Elman
DFDavid R. Flum
David R. Flum
DKDavid E. Kleiner
David E. Kleiner
Postbariatric hypoglycemia (PBH) can be a devastating complication for which current therapies are often incompletely effective. More information is needed regarding frequency, incidence, and risk factors for PBH. To examine hypoglycemia symptoms following Roux-en-Y gastric bypass (RYGB) and laparoscopic adjustable gastric banding (LAGB) and baseline and in-study risk factors. Multicenter, at 10 US hospitals in 6 geographically diverse clinical centers. A prospective, longitudinal cohort study of adults undergoing RYGB or LAGB as part of clinical care between 2006 and 2009 were recruited and followed until January 31, 2015, with baseline and annual postoperative research assessments. We analyzed baseline prevalence and post-operative incidence and frequency of self-reported hypoglycemia symptoms as well as potential preoperative risk factors. In all groups, postoperative prevalence of hypoglycemia symptoms was 38.5%. Symptom prevalence increased postoperatively from 2.8%-36.4% after RYGB in patients without preoperative diabetes (T2D), with similar patterns in prediabetes (4.9%-29.1%). Individuals with T2D had higher baseline hypoglycemia symptoms (28.9%), increasing after RYGB (57.9%). Hypoglycemia symptoms were lower after LAGB, with 39.1% reported hypoglycemia symptoms at only 1 postoperative visit with few (4.0%) having persistent symptoms at 6 or more annual visits. Timing of symptoms was not restricted to the postprandial state. Symptoms of severe hypoglycemia were reported in 2.6-3.6% after RYGB. The dominant risk factor for postoperative symptoms was preoperative symptoms; additionally, baseline selective serotonin (SSRI) and serotonin-norepinephrine (SNRI) reuptake inhibitor use was also associated with increased risk in multivariable analysis. Weight loss and regain were not related to hypoglycemia symptom reporting. Hypoglycemia symptoms increase over time after RYGB, particularly in patients without diabetes. In a small percentage, symptoms can be persistent or severe and require hospitalization. Preoperative hypoglycemia symptoms and SSRI/SNRI use in RYGB patients without diabetes is associated with increased risk of symptoms.

5 October 2018 in International Journal for Numerical Methods in Engineering
Verified
Journal Article
Closed access
PDF file
RCRicardo Costa
Ricardo Costa
JNJoão Nóbrega
João Nóbrega
SCStéphane Clain
Stéphane Clain
GMGaspar J. Machado
Gaspar J. Machado
RLRaphaël Loubère
Raphaël Loubère

1 December 2019 in Computer Methods in Applied Mechanics and Engineering
Verified
Journal Article
Closed access
RCRicardo Costa
Ricardo Costa
JNJoão Nóbrega
João Nóbrega
SCStéphane Clain
Stéphane Clain
GMGaspar J. Machado
Gaspar J. Machado

1 November 2021 in Journal of Computational Physics
Verified
Journal Article
Closed access
RCRicardo Costa
Ricardo Costa
JNJoão Nóbrega
João Nóbrega
SCStéphane Clain
Stéphane Clain
GMGaspar J. Machado
Gaspar J. Machado

16 May 2022 in Computer Methods in Applied Mechanics and Engineering
Verified
Journal Article
Closed access
RCRicardo Costa
Ricardo Costa
SCStéphane Clain
Stéphane Clain
GMGaspar J. Machado
Gaspar J. Machado
JNJoão Nóbrega
João Nóbrega

29 July 2023 in Computer Methods in Applied Mechanics and Engineering
Verified
Journal Article
Open access
RCRicardo Costa
Ricardo Costa
SCStéphane Clain
Stéphane Clain
GMGaspar J. Machado
Gaspar J. Machado
JNJoão Nóbrega
João Nóbrega
HVHugo Beirão da Veiga
Hugo Beirão da Veiga
FCFrancesca Crispo
Francesca Crispo